However, when the FoxP3 marker was also considered for Treg identification, the abundance of CD4+CD25+FoxP3+ T cells was higher in the CSF than in the peripheral blood from CIS, RRMS, and SPMS patients [113,114]. This evidence concerns the gene FOXP3 and in situ carcinoma.